Junshi Biosciences chairman boosts stake in ongoing shareholding plan

Shanghai Junshi Biosciences Co., Ltd. announced that its chairman, Xiong Jun, who is also a controlling shareholder, has increased his shareholding in the company. As of the announcement date, Xiong Jun acquired 100,000 A shares through the Shanghai Stock Exchange's centralized bidding platform, representing 0.01% of the total share capital. The total transaction amount for this increase was RMB3,838,400.

This share increase is part of an ongoing plan by Xiong Jun, initiated on April 12, 2025, to boost his stake in both A and H shares. He aims to increase his total shareholding by no less than RMB100 million, with at least RMB50 million allocated to A shares, over a 12-month period ending April 11, 2026. This latest transaction occurred on November 10, 2025.

As of the announcement date, Xiong Jun, along with Xiong Fengxiang and other parties acting in concert, hold a combined 184,083,186 shares, which represents approximately 17.93% of the company's total share capital. The company noted that the plan to increase shareholding is not yet complete.